Bond Labs third fiscal quarter revenue increases 58%

NewsGuard 100/100 Score

Bond Laboratories, Inc. (OTCBB:BNLB) ("Bond Labs"), a national provider of innovative and proprietary nutritional supplements for health conscious consumers, today announced continued significant revenue growth and positive net income for the third fiscal quarter of 2011. Revenue for the quarter ended September 30, 2011 grew to $3.2 million as compared to $2.0 million for the quarter ended September 30, 2010, an increase of 58%. Bond Labs also reported its third consecutive quarter with positive net income, posting a profit of $291,000 for the quarter ended September 30, 2011 as compared to a net loss of ($560,000) for the same period last year. Year to date, Bonds Labs reported revenue and net income of $9.4 million and $782,000, respectively, for the nine month period ended September 30, 2011 as compared to revenue of $6.4 million and a net loss and ($1.5) million for the comparable period last year.

"We are thrilled to again report both continued, notable revenue growth and positive net income for the third consecutive fiscal quarter. Our year-to-date revenue increased 45%, or almost $3 million, over the comparable period last year. Perhaps even more significant, our year-to-date net income increased almost $2.4 million as compared to our results from the nine months ended September 30, 2010," commented Bond Labs CEO, John S. Wilson.

"Our growth strategy, which includes increasing the number of GNC franchised outlets selling NDS products and launching new innovative products that create significant value for both Bond Labs and our GNC franchise partners, continues to produce strong results. Over the last twenty-one months, we have increased the number of franchise locations in our distribution system by over 150%, from approximately 320 at the end of 2009 to more than 800 today. In addition to that, we introduced 14 new highly successful and innovative products into GNC's distribution system. I am truly excited about our prospects, not just for the remainder of the year, but for 2012 and beyond," concluded Mr. Wilson.

Source:

Bond Laboratories

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Caffeine vs. creatine: The impact on cognitive and physical performances